산업 일반
"Hey Siri, when did you go into those glasses?... Apple also plans to release next year

According to Bloomberg on the 22nd (local time), Apple aims to begin mass production of smart glasses prototypes by the end of this year, targeting a launch in late next year to compete with Ray Ban sunglasses of Meta.
Apple's smart glasses are expected to feature a camera, microphone, and speakers, allowing them to analyze the outside world. Apple's voice assistant "Siri" will recognize this information and provide relevant feedback to the user.
In addition to making phone calls, the glasses are expected to to support music playback, real-time translation, and navigation functions.
Apple's ultimate goal is to release augmented reality(AR) glasses.
On the 20th, Google showcased AI-powered smart glasses during its annual conference. The prototype glasses were co-developed with Samsung Electronics.
Shahram Izadi, Vice President of Android XR at Google, introduced the glasses by saying, “We’re bringing the power of Gemini Live — a natural form of AI — to where you are,” and added, “Wearing these glasses feels like gaining superpowers.”
The AI can recognize visuals in real-time as if it were seeing, enabling it to converse with people. Through the camera embedded in the glasses, the AI can understand the surrounding environment and provide real-time translations displayed as subtitles.
Meta has been releasing smart glasses in partnership with Ray-Ban since 2021. These glasses include features such as photo and video capture, phone calls, music playback, and basic AI capabilities.
▶원문 기사: "시리야 언제 안경 속에 들어갔어?"…애플도 내년 출시 계획 (이코노미스트 2025.5.23)

ⓒ이코노미스트(https://economist.co.kr) '내일을 위한 경제뉴스 이코노미스트' 무단 전재 및 재배포 금지
당신이 좋아할 만한 기사
브랜드 미디어
브랜드 미디어
이스라엘 타격에도 이란 핵시설 상당부분 온전
세상을 올바르게,세상을 따뜻하게일간스포츠
이데일리
일간스포츠
가수 선언한 애니..정유경 회장 "말도 안돼"
대한민국 스포츠·연예의 살아있는 역사 일간스포츠일간스포츠
일간스포츠
일간스포츠
이스라엘 타격에도 이란 핵시설 상당부분 온전
세상을 올바르게,세상을 따뜻하게이데일리
이데일리
이데일리
[마켓인]엠플러스자산운용 매각 결국 불발…"수의계약 전환 고려"
성공 투자의 동반자마켓인
마켓인
마켓인
HLB테라퓨틱스, 3상 결과 기대로 상승…애드바이오텍 연속 上 종료 [바이오맥짚기]
바이오 성공 투자, 1%를 위한 길라잡이팜이데일리
팜이데일리
팜이데일리